Panminerva medica
-
Meta Analysis
Metabolic syndrome and risk of prostate cancer: a systematic review and meta-analysis.
Emerging evidence supports the hypothesis that metabolic syndrome is associated with cancer pathogenesis. In particular regarding prostate cancer, observational studies from various settings report different results. This systematic review and meta-analysis aimed to provide a quantitative estimate of the association between metabolic syndrome in prostate cancer, in particular Gleason Score >6, accounting for different study designs. ⋯ Growing evidence support the association between metabolic syndrome and prostate cancer, bias derived from observational studies might conceal further findings.